KOPS - The Institutional Repository of the University of Konstanz

The synthetic peptide LyeTxI-b derived from Lycosa erythrognatha spider venom is cytotoxic to U-87 MG glioblastoma cells

The synthetic peptide LyeTxI-b derived from Lycosa erythrognatha spider venom is cytotoxic to U-87 MG glioblastoma cells

Cite This

Files in this item

Checksum: MD5:7d392c1ba2c6bdc3652abed4030460ad

ABDEL-SALAM, Mostafa A. L., Juliana CARVALHO-TAVARES, Kamila Sousa GOMES, Andrea TEIXEIRA-CARVALHO, Gregory T. KITTEN, Johanna NYFFELER, Felipe F. DIAS, Pablo V. Mendes DOS REIS, Marcel LEIST, Elaine Maria DE SOUZA-FAGUNDES, 2019. The synthetic peptide LyeTxI-b derived from Lycosa erythrognatha spider venom is cytotoxic to U-87 MG glioblastoma cells. In: Amino acids. 51(3), pp. 433-449. ISSN 0939-4451. eISSN 1438-2199. Available under: doi: 10.1007/s00726-018-2678-4

@article{AbdelSalam2019-03synth-44643, title={The synthetic peptide LyeTxI-b derived from Lycosa erythrognatha spider venom is cytotoxic to U-87 MG glioblastoma cells}, year={2019}, doi={10.1007/s00726-018-2678-4}, number={3}, volume={51}, issn={0939-4451}, journal={Amino acids}, pages={433--449}, author={Abdel-Salam, Mostafa A. L. and Carvalho-Tavares, Juliana and Gomes, Kamila Sousa and Teixeira-Carvalho, Andrea and Kitten, Gregory T. and Nyffeler, Johanna and Dias, Felipe F. and Dos Reis, Pablo V. Mendes and Leist, Marcel and de Souza-Fagundes, Elaine Maria} }

<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/44643"> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:contributor>Teixeira-Carvalho, Andrea</dc:contributor> <dcterms:issued>2019-03</dcterms:issued> <dc:contributor>Dias, Felipe F.</dc:contributor> <dcterms:abstract xml:lang="eng">Antimicrobial peptides present a broad spectrum of therapeutic applications, including their use as anticancer peptides. These peptides have as target microbial, normal, and cancerous cells. The oncological properties of these peptides may occur by membranolytic mechanisms or non-membranolytics. In this work, we demonstrate for the first time the cytotoxic effects of the cationic alpha-helical antimicrobial peptide LyeTx I-b on glioblastoma lineage U87-MG. The anticancer property of this peptide was associated with a membranolytic mechanism. Loss of membrane integrity occurred after incubation with the peptide for 15 min, as shown by trypan blue uptake, reduction of calcein-AM conversion, and LDH release. Morphological studies using scanning electron microscopy demonstrated disruption of the plasma membrane from cells treated with LyeTx I-b, including the formation of holes or pores. Transmission electron microscopy analyses showed swollen nuclei with mild DNA condensation, cell volume increase with an electron-lucent cytoplasm and organelle vacuolization, but without the rupture of nuclear or plasmatic membranes. Morphometric analyses revealed a high percentage of cells in necroptosis stages, followed by necrosis and apoptosis at lower levels. Necrostatin-1, a known inhibitor of necroptosis, partially protected the cells from the toxicity of the peptide in a concentration-dependent manner. Imaging flow cytometry confirmed that 59% of the cells underwent necroptosis after 3-h incubation with the peptide. It is noteworthy that LyeTx I-b showed only mild cytotoxicity against normal fibroblasts of human and monkey cell lines and low hemolytic activity in human erythrocytes. All data together point out the anticancer potential of this peptide.</dcterms:abstract> <dc:creator>Nyffeler, Johanna</dc:creator> <dc:creator>Gomes, Kamila Sousa</dc:creator> <dc:creator>Carvalho-Tavares, Juliana</dc:creator> <dc:contributor>Nyffeler, Johanna</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:contributor>Carvalho-Tavares, Juliana</dc:contributor> <dc:contributor>Leist, Marcel</dc:contributor> <dc:contributor>Abdel-Salam, Mostafa A. L.</dc:contributor> <dc:contributor>Gomes, Kamila Sousa</dc:contributor> <dc:creator>Leist, Marcel</dc:creator> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/44643/1/Abdel-Salam_2-v3vqcwy8ahp01.pdf"/> <dc:creator>Abdel-Salam, Mostafa A. L.</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-21T12:34:17Z</dcterms:available> <dc:creator>Dias, Felipe F.</dc:creator> <dcterms:title>The synthetic peptide LyeTxI-b derived from Lycosa erythrognatha spider venom is cytotoxic to U-87 MG glioblastoma cells</dcterms:title> <dc:language>eng</dc:language> <dc:contributor>de Souza-Fagundes, Elaine Maria</dc:contributor> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:rights>terms-of-use</dc:rights> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/44643/1/Abdel-Salam_2-v3vqcwy8ahp01.pdf"/> <dc:creator>Dos Reis, Pablo V. Mendes</dc:creator> <dc:creator>de Souza-Fagundes, Elaine Maria</dc:creator> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-21T12:34:17Z</dc:date> <dc:creator>Teixeira-Carvalho, Andrea</dc:creator> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/44643"/> <dc:creator>Kitten, Gregory T.</dc:creator> <dc:contributor>Kitten, Gregory T.</dc:contributor> <dc:contributor>Dos Reis, Pablo V. Mendes</dc:contributor> </rdf:Description> </rdf:RDF>

Downloads since Jan 21, 2019 (Information about access statistics)

Abdel-Salam_2-v3vqcwy8ahp01.pdf 126

This item appears in the following Collection(s)

Search KOPS


Browse

My Account